OSTEOPONTIN FOR THE PREDICTION AND TREATMENT OF CARDIOVASCULAR DISEASES

摘要

Osteopontin for the prediction and treatment of cardiovascular diseases T he present invention relates to the use of endothelial progenitor cells (EPC s) and osteopontin for the treatment of cardiovascular diseases or complicat ions. The invention also relates to the use of EPC osteopontin levels as a m arker of the risk of the development of these cardiovascular complications. In particular, the invention provides compositions and methods based on oste opontin and the genes encoding osteopontin.